(19)
(11) EP 0 779 923 A2

(12)

(43) Date of publication:
25.06.1997 Bulletin 1997/26

(21) Application number: 95934482.0

(22) Date of filing: 11.09.1995
(51) International Patent Classification (IPC): 
C12N 15/ 02( . )
A61K 39/ 395( . )
A61P 29/ 00( . )
A61P 37/ 00( . )
C07K 16/ 28( . )
C12N 15/ 09( . )
C12P 21/ 02( . )
C12Q 1/ 68( . )
 A61K 38/ 00( . )
A61P 25/ 00( . )
A61P 31/ 04( . )
C07K 14/ 715( . )
C12N 5/ 10( . )
C12N 15/ 12( . )
C12P 21/ 08( . )
C12R 1/ 91( . )
(86) International application number:
PCT/US1995/012037
(87) International publication number:
WO 1996/007739 (14.03.1996 Gazette 1996/12)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 09.09.1994 US 19940303957

(71) Applicant: NEUROCRINE BIOSCIENCES, INC.
San Diego, CA 92121-1102 (US)

(72) Inventors:
  • LOVENBERG, Timothy, W.
    Carlsbad, CA 92009 (US)
  • OLTERSDORF, Tilman
    Cardiff, CA 92007 (US)
  • LIAW, Chen, W.
    San Diego, CA 92129 (US)
  • CLEVENGER, William
    Vista, CA 92083 (US)
  • DeSOUZA, Errol, B.
    Del Mar, CA 92014 (US)

(74) Representative: Gowshall, Jonathan Vallance, et al 
FORRESTER & BOEHMERT Franz-Joseph-Strasse 38
80801 München
80801 München (DE)

   


(54) INTERLEUKIN-1 TYPE 3 RECEPTORS